Multidimensional immune profiling of cutaneous lupus erythematosus in vivo stratified by patient response to antimalarials
Objective The pathogenesis of cutaneous lupus erythematosus (CLE) is multifactorial, and
CLE is difficult to treat due to the heterogeneity of inflammatory processes among patients. …
CLE is difficult to treat due to the heterogeneity of inflammatory processes among patients. …
[HTML][HTML] Bullous systemic lupus erythematosus in females
G Sprow, M Afarideh, J Dan, ML Hedberg… - International Journal of …, 2022 - journals.lww.com
Bullous systemic lupus erythematosus (BSLE) is a rare blistering presentation of systemic
lupus erythematosus, typically affecting women with the highest incidence in those of African …
lupus erythematosus, typically affecting women with the highest incidence in those of African …
Cutaneous involvement in systemic lupus erythematosus: a review for the rheumatologist
C Stull, G Sprow, VP Werth - The Journal of rheumatology, 2023 - jrheum.org
The majority of patients with systemic lupus erythematosus (SLE) have cutaneous manifestations
at some point in their disease course. The skin findings in SLE are classified as SLE-…
at some point in their disease course. The skin findings in SLE are classified as SLE-…
[HTML][HTML] Autoimmune skin disease exacerbations following COVID-19 vaccination
Background Vaccination against COVID-19 reduces the risk of severe COVID-19 disease
and death. However, few studies have examined the safety of the COVID-19 vaccine in …
and death. However, few studies have examined the safety of the COVID-19 vaccine in …
[HTML][HTML] Sclerotic skin disease development following COVID-19 vaccination
G Sprow, J Dan, J Abbott, A Jiang, DA Diaz… - JAAD Case Reports, 2022 - Elsevier
Discussion We present 2 cases with prior rheumatic cutaneous disease who progressed to
new-onset sclerotic skin disease following receipt of mRNA vaccines against COVID-19. To …
new-onset sclerotic skin disease following receipt of mRNA vaccines against COVID-19. To …
[HTML][HTML] Emerging therapies in cutaneous lupus erythematosus
G Sprow, J Dan, JF Merola, VP Werth - Frontiers in Medicine, 2022 - frontiersin.org
Cutaneous lupus erythematosus (CLE) is an autoimmune disease that can occur with or
without underlying systemic lupus erythematosus (SLE) and often has a profoundly negative …
without underlying systemic lupus erythematosus (SLE) and often has a profoundly negative …
Risk of cerebrovascular events among childhood and adolescent patients receiving cranial radiation therapy: a pediatric normal tissue effects in the clinic normal …
…, PJ Taddei, LS Constine, G Sprow… - International Journal of …, 2022 - Elsevier
Purpose Radiation-induced cerebrovascular toxicity is a well-documented sequelae that
can be both life-altering and potentially fatal. We performed a meta-analysis of the relevant …
can be both life-altering and potentially fatal. We performed a meta-analysis of the relevant …
A comparison of the efficacy of Skindex-16 and Skindex-29 in dermatomyositis
Recently, more emphasis has been placed on patient-reported outcomes in clinical trials,
which has inadvertently led to an increase in respondent burden. In this study, we found that …
which has inadvertently led to an increase in respondent burden. In this study, we found that …
Distinguishing monkeypox from its mimickers.
G Sprow, M Toker, U Khanna, B Wu - Journal of Medical Virology, 2023 - europepmc.org
Herein, we present a simple guide to help clinicians distinguish monkeypox from other
common diseases with similar presentations along with the initial diagnostic workup for …
common diseases with similar presentations along with the initial diagnostic workup for …
Plasmacytoid dendritic cells are not major producers of type 1 interferon in cutaneous lupus: An in depth immunoprofile of subacute and discoid lupus
…, F Chin, E Keyes, M Sharma, G Sprow… - Journal of Investigative …, 2023 - Elsevier
The immunologic drivers of cutaneous lupus erythematosus (CLE) and its clinical subtypes
remains poorly understood. We sought to characterize the immune landscape of discoid …
remains poorly understood. We sought to characterize the immune landscape of discoid …